Phosphodiesterase 3 (PDE3) inhibitors

AU2024234735B2Pending Publication Date: 2026-09-10ZOETIS SERVICES LLC
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
AU2024234735
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-01-30
Filing Date
2024-03-07
Publication Date
2026-09-10
Patent Text Reader

Abstract

The invention describes novel PDE3 inhibitors for treating a cardiovascular disease including myxomatous mitral valve disease, congestive heart failure and / or asymptomatic heart failure in animals, particularly canines.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Benzimidazoles, their preparation and pharmaceutical compositions containing them

    EP0008391A1

  • Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same

    EP0132817A1

  • Indoline and 2-indolinone derivatives

    EP0161918A2

  • Thiadiazinones

    EP0294647A2

  • Isatine derivatives with neurotrophic activity

    WO2001055110A1